Chart calendar Perspective Therapeutics, Inc.

4242b88d55d1ffc59c031220e950.W6CGhuY8Z-oap8ZQLec-nP755896rPv3svvaBjpxoO0.E9r-wZxUX6l4ip8kbIVS253U0IU0lJaY5YmRYkhByrsV7fC3lH8qiSvqqQ~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

No events available

Past events on Perspective Therapeutics, Inc.

2026-05-27

Annual General Meeting

10:00
2026-05-11

Earnings release - Q1 2026

2026-05-04

Présentation aux Actionnaires / Analystes

08:30
2026-03-16

Earnings release - Annual 2025

2025-11-10

Earnings release - Q3 2025

2025-10-20

Information meeting

08:30
2025-08-13

Earnings release - Q2 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
1,43
8,46
-83.04%
1,45
1,46
-0.34%
0,88
1,07
-17.46%

0,42


0,49


13,5

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-64,5
-62,5
-3.18%
-110
-102
-8.35%

-127


-144


-153

EBIT
Million USD
Released
Forecast
Spread
-40,9
-43,4
5.6%
-66,8
-67,1
0.48%
-114
-103
-9.76%

-125


-145


-144

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-40,1
-43,0
6.64%
-80,4
-58,1
-38.42%
-104
-95,1
-9.84%

-120


-137


-132

Net income
Million USD
Released
Forecast
Spread
-46,5
-37,7
-23.33%
-79,3
-58,0
-36.62%
-103
-94,1
-9.57%

-120


-138


-137

EPS
USD
Released
Forecast
Spread
-1,70
-1,40
-21.43%
-1,23
-0,66
-87.27%
-1,40
-1,25
-11.82%

-1,10


-1,13


-1,07

Announcement Date28/03/2426/03/2516/03/26-

Quarterly results

Fiscal PeriodMarch 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,37
0,24
55.1%
0,23
0,28
-15.61%
0,34
0,14
137.62%
0,29
0,17
70.22%
0,21
0,21
1.04%
0,04
0,24
-81.86%
0,08
0,14
-44.6%

0,09


0,09


0,10


0,06


0,02


0,02


0,02

EBITDA
Million USD
Released
Forecast
Spread
-18,0
-14,5
-24.32%
-20,2
-17,6
-14.42%
-21,1
-19,5
-7.96%
-23,3
-19,8
-17.54%
-27,1
-21,7
-24.85%
-38,8
-25,5
-52.26%
-27,2
-39,7
31.6%

-29,2


-32,9


-37,6













EBIT
Million USD
Released
Forecast
Spread
-18,6
-16,5
-12.86%
-20,9
-21,2
1.47%
-21,8
-23,0
5.05%
-24,0
-24,0
-0.28%
-27,9
-26,0
-7.32%
-39,8
-29,7
-33.98%
-28,3
-33,9
16.5%

-30,5


-32,4


-34,3


-32,8


-34,0


-35,1


-36,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-15,1
-14,5
-4.09%
-41,3
-18,6
-122.37%
-18,2
-22,4
18.96%
-22,0
-22,5
2.33%
-26,0
-24,6
-5.7%
-38,3
-29,0
-31.92%
-26,2
-32,0
18.19%

-29,1


-31,1


-32,9


-31,5


-32,4


-33,5


-34,2

Net income
Million USD
Released
Forecast
Spread
-15,1
-14,6
-3.88%
-40,2
-18,5
-116.65%
-18,2
-22,4
18.96%
-21,5
-22,1
2.64%
-26,0
-24,4
-6.41%
-37,5
-28,3
-32.38%
-26,2
-32,2
18.77%

-29,0


-31,1


-33,4


-31,4


-32,6


-33,8


-34,8

EPS
USD
Released
Forecast
Spread
-0,21
-0,19
-9.65%
-0,61
-0,24
-152.55%
-0,25
-0,31
18.34%
-0,29
-0,30
2.08%
-0,35
-0,32
-7.88%
-0,51
-0,36
-40.94%
-0,25
-0,30
17.03%

-0,26


-0,27


-0,29


-0,30


-0,31


-0,30


-0,30

Announcement Date12/11/2426/03/2512/05/2513/08/2510/11/2516/03/2611/05/26-------
Today

Earnings release - Q2 2026

Today

Earnings release - Q2 2026

Today

Earnings presentation

08:30
Today

Earnings presentation

08:00
Today

Earnings release - Q2 2026

Today

Earnings release - Q1 2027

Today

Annual General Meeting

06:00
Today

Présentation aux Actionnaires / Analystes

06:00
2026-07-29

Earnings presentation

23:30
2026-07-30

Earnings presentation

08:00

Past sector events for Perspective Therapeutics, Inc.

2026-07-28

Earnings presentation

09:00
2026-07-28

Earnings release - Q2 2026

2026-07-28

Earnings release - Q2 2026

2026-07-28

Earnings presentation

08:00
Today

Board of Directors Meeting

2026-07-25

Earnings presentation

00:30
2026-07-24

Board of Directors Meeting

07:00
2026-07-24

Earnings release - Q1 2027

2026-07-23

Earnings presentation

09:00
2026-07-23

Earnings presentation

08:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CATX Stock
  4. Calendar Perspective Therapeutics, Inc.